162 related articles for article (PubMed ID: 37518825)
1. Ipsilateral tumor recurrence risk in women with ductal carcinoma in situ: application of the Van Nuys Prognostic Index and the Memorial Sloan Kettering Cancer Center nomogram.
Hashiba KA; Bahl M
Breast Cancer Res Treat; 2023 Nov; 202(1):185-190. PubMed ID: 37518825
[TBL] [Abstract][Full Text] [Related]
2. Prognostic Significance of Clinicopathologic Features in Patients With Breast Ductal Carcinoma-in-Situ Who Received Breast-Conserving Surgery.
Kuo SH; Lo C; Chen YH; Lien HC; Kuo WH; Wang MY; Lee YH; Huang CS
Clin Breast Cancer; 2018 Dec; 18(6):441-450.e2. PubMed ID: 29709458
[TBL] [Abstract][Full Text] [Related]
3. Local relapse after breast-conserving therapy for ductal carcinoma in situ: a European single-center experience and external validation of the Memorial Sloan-Kettering Cancer Center DCIS nomogram.
Sweldens C; Peeters S; van Limbergen E; Janssen H; Laenen A; Patil S; Van Zee KJ; Weltens C
Cancer J; 2014; 20(1):1-7. PubMed ID: 24445756
[TBL] [Abstract][Full Text] [Related]
4. Validation of a nomogram in the prediction of local recurrence risks after conserving surgery for Asian women with ductal carcinoma in situ of the breast.
Wang F; Li H; Tan PH; Chua ET; Yeo RM; Lim FL; Kim SW; Tan DY; Wong FY
Clin Oncol (R Coll Radiol); 2014 Nov; 26(11):684-91. PubMed ID: 25194727
[TBL] [Abstract][Full Text] [Related]
5. Value of the Van Nuys Prognostic Index in prediction of recurrence of ductal carcinoma in situ after breast-conserving surgery.
Boland GP; Chan KC; Knox WF; Roberts SA; Bundred NJ
Br J Surg; 2003 Apr; 90(4):426-32. PubMed ID: 12673743
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of a breast cancer nomogram for predicting risk of ipsilateral breast tumor recurrences in patients with ductal carcinoma in situ after local excision.
Yi M; Meric-Bernstam F; Kuerer HM; Mittendorf EA; Bedrosian I; Lucci A; Hwang RF; Crow JR; Luo S; Hunt KK
J Clin Oncol; 2012 Feb; 30(6):600-7. PubMed ID: 22253459
[TBL] [Abstract][Full Text] [Related]
7. 259 Patients with DCIS of the breast applying USC/Van Nuys prognostic index: a retrospective review with long term follow up.
Di Saverio S; Catena F; Santini D; Ansaloni L; Fogacci T; Mignani S; Leone A; Gazzotti F; Gagliardi S; De Cataldis A; Taffurelli M
Breast Cancer Res Treat; 2008 Jun; 109(3):405-16. PubMed ID: 17687650
[TBL] [Abstract][Full Text] [Related]
8. The significance of the Van Nuys prognostic index in the management of ductal carcinoma in situ.
Gilleard O; Goodman A; Cooper M; Davies M; Dunn J
World J Surg Oncol; 2008 Jun; 6():61. PubMed ID: 18564426
[TBL] [Abstract][Full Text] [Related]
9. Application of the van nuys prognostic index in a retrospective series of 367 ductal carcinomas in situ of the breast examined by serial macroscopic sectioning: practical considerations.
de Mascarel I; Bonichon F; MacGrogan G; de Lara CT; Avril A; Picot V; Durand M; Mauriac L; Trojani M; Coindre JM
Breast Cancer Res Treat; 2000 May; 61(2):151-9. PubMed ID: 10942101
[TBL] [Abstract][Full Text] [Related]
10. A Comparison of Predicted Ipsilateral Tumor Recurrence Risks in Patients With Ductal Carcinoma in Situ of the Breast After Breast-Conserving Surgery by Breast Radiation Oncologists, the Van Nuys Prognostic Index, the Memorial Sloan Kettering Cancer Center DCIS Nomogram, and the 12-Gene DCIS Score Assay.
Lei RY; Carter DL; Antell AG; Nowels MA; Tole SP; Bennett JP; Turner M; Baehner FL; Leonard CE
Adv Radiat Oncol; 2021; 6(2):100607. PubMed ID: 33912731
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic strategy for ductal carcinoma in situ patients according to Van Nuys Prognostic Index.
Andretta M; Scomersi S; Urbani M; Bortul M
Ann Ital Chir; 2014; 85(3):254-9. PubMed ID: 25074533
[TBL] [Abstract][Full Text] [Related]
12. Risk Prediction for Local Breast Cancer Recurrence Among Women with DCIS Treated in a Community Practice: A Nested, Case-Control Study.
Collins LC; Achacoso N; Haque R; Nekhlyudov L; Quesenberry CP; Schnitt SJ; Habel LA; Fletcher SW
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S502-8. PubMed ID: 26059650
[TBL] [Abstract][Full Text] [Related]
13. Local treatment options for young women with ductal carcinoma in situ: A systematic review and meta-analysis comparing breast conserving surgery with or without adjuvant radiotherapy, and mastectomy.
Chien JC; Liu WS; Huang WT; Shih LC; Liu WC; Chen YC; Chou KJ; Shiue YL; Lin PC
Breast; 2022 Jun; 63():29-36. PubMed ID: 35299032
[TBL] [Abstract][Full Text] [Related]
14. Comparison of ipsilateral breast tumor recurrence after breast-conserving surgery between ductal carcinoma in situ and invasive breast cancer.
Choi YJ; Shin YD; Song YJ
World J Surg Oncol; 2016 Apr; 14():126. PubMed ID: 27122132
[TBL] [Abstract][Full Text] [Related]
15. Treatment selection for patients with ductal carcinoma in situ (DCIS) of the breast using the University of Southern California/Van Nuys (USC/VNPI) prognostic index.
Silverstein MJ; Lagios MD
Breast J; 2015; 21(2):127-32. PubMed ID: 25600630
[TBL] [Abstract][Full Text] [Related]
16. Management of ductal carcinoma in situ according to Van Nuys Prognostic Index in Australia and New Zealand.
Whitfield R; Kollias J; de Silva P; Turner J; Maddern G
ANZ J Surg; 2012; 82(7-8):518-23. PubMed ID: 22758922
[TBL] [Abstract][Full Text] [Related]
17. The value of the Van Nuys Prognostic Index in ductal carcinoma in situ of the breast: a retrospective analysis.
Asjoe FT; Altintas S; Huizing MT; Colpaert C; Marck EV; Vermorken JB; Tjalma WA
Breast J; 2007; 13(4):359-67. PubMed ID: 17593040
[TBL] [Abstract][Full Text] [Related]
18. An attempt to independently verify the utility of the Van Nuys Prognostic Index for ductal carcinoma in situ.
MacAusland SG; Hepel JT; Chong FK; Galper SL; Gass JS; Ruthazer R; Wazer DE
Cancer; 2007 Dec; 110(12):2648-53. PubMed ID: 17960606
[TBL] [Abstract][Full Text] [Related]
19. Analyzing the risk of recurrence after mastectomy for DCIS: a new use for the USC/Van Nuys Prognostic Index.
Kelley L; Silverstein M; Guerra L
Ann Surg Oncol; 2011 Feb; 18(2):459-62. PubMed ID: 20859695
[TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of oncogenic markers in ductal carcinoma in situ of the breast: a clinicopathologic study.
Altintas S; Lambein K; Huizing MT; Braems G; Asjoe FT; Hellemans H; Van Marck E; Weyler J; Praet M; Van den Broecke R; Vermorken JB; Tjalma WA
Breast J; 2009; 15(2):120-32. PubMed ID: 19292797
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
